Tyra Biosciences, Inc.

TYRA Net buying

CIK 0001863127 #2234 in the set updated 17 Sep 2026

Bought (120 mo)

$76.97M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$31.98M

$18.29M on a plan · $5.14M straight out of an exercise

Sold at will

$8.54M

33 of 134 sales

Net

+$44.99M

+$68.43M against sales at will

By person

23 insiders · 150 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

RA CAPITAL MANAGEMENT, L.P. entity

Director

$55.16M (8)

—

+$55.16M

10,259,291

17.19%

$211.12M

—

Boxer Capital, LLC entity

See Remarks

$11.64M (2)

—

+$11.64M

6,534,298

10.95%

$134.47M

—

Bensen Daniel

Chief Discovery Officer

—

$9.54M (55) scheduled

−$9.54M

146,981

0.2463%

$3.02M

−71.7%

Harris Todd

President and CEO

—

$8.12M (43) scheduled

−$8.12M

1,437,631

2.41%

$29.58M

−13.5%

Cormorant Asset Management, LP entity

Former 10% Owner

$5.00M (1)

—

+$5.00M

1,069,932

1.79%

$22.02M

—

Kjellson Nina S

Director

—

$4.41M (26)

−$4.41M

443,885

0.7438%

$9.13M

—

MVA Investors, LLC entity

10% owner

—

$3.50M (2)

−$3.50M

22,527

0.0377%

$463.57K

−92.2%

MORE ROBERT J

Director

$2.50M (1)

$5.25M (2) scheduled

−$2.75M

3,823,425

6.41%

$78.68M

+3,286%

Alta Partners NextGen Fund II Management, LLC entity

10% owner

$2.50M (1)

—

+$2.50M

4,080,296

6.84%

$83.97M

+3,513%

KAPLAN GILLA

Director

—

$1.16M (6)

−$1.16M

28,231

0.0473%

$580.95K

−79.0%

Fuhrman Alan

Chief Financial Officer

$151.95K (1)

—

+$151.95K

36,164

0.0606%

$744.20K

—

Verjee Rehan

Director

$20.00K (1)

—

+$20.00K

972

0.0016%

$20.00K

—

Boxer Capital Management, LLC entity

See remarks

—

—

—

4,448,359

7.45%

$91.54M

−31.0%

Canaan XI L.P.

10% owner

—

—

—

473,396

0.7933%

$9.74M

—

Hudkins Robert L.

Chief Technology Officer

—

—

—

273,576

0.4584%

$5.63M

+1.3%

Swanson Ronald V.

Chief Scientific Officer

—

—

—

273,254

0.4579%

$5.62M

+1.2%

CHEN ISAN

Director

—

—

—

192,783

0.3230%

$3.97M

+46.8%

van den Boom Esther

Chief Financial Officer

—

—

—

143,151

0.2399%

$2.95M

+20.7%

Tada Hiroomi

Chief Medical Officer

—

—

—

86,435

0.1448%

$1.78M

+10.9%

Patel Piyush R.

Chief Development Officer

—

—

—

73,794

0.1237%

$1.52M

−45.4%

Rueb Yuliya

Vice President, Finance (PAO)

—

—

—

43,354

0.0726%

$892.16K

+23.8%

Warner Douglas J

Chief Medical Officer

—

—

—

25,000

0.0419%

$514.46K

—

Ashar Bhavesh

Chief Operating Officer

—

—

—

15,013

0.0252%

$308.94K

—

Individual transactions

1

Insider

Date

Role

Action

Shares

Price

Amount

KAPLAN GILLA

13 Jun 2024

Director

Exercised, kept

61,392

$0.61

$37.45K

Show all 150 transactions →

What was left out

Form 4 filings counted 167

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 19

Sales on a Rule 10b5-1 plan 58

Sales straight out of an exercise 43

Sales at will 33

Transactions with no price 0

Shares from compensation/vesting 36,208,337

Sales filed before the plan box existed 2

History held since 17 Sep 2021